全文获取类型
收费全文 | 1621篇 |
免费 | 100篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 67篇 |
妇产科学 | 21篇 |
基础医学 | 163篇 |
口腔科学 | 14篇 |
临床医学 | 158篇 |
内科学 | 432篇 |
皮肤病学 | 25篇 |
神经病学 | 44篇 |
特种医学 | 364篇 |
外科学 | 190篇 |
综合类 | 11篇 |
一般理论 | 2篇 |
预防医学 | 47篇 |
眼科学 | 10篇 |
药学 | 85篇 |
中国医学 | 4篇 |
肿瘤学 | 88篇 |
出版年
2021年 | 12篇 |
2018年 | 15篇 |
2017年 | 18篇 |
2016年 | 23篇 |
2015年 | 33篇 |
2014年 | 33篇 |
2013年 | 45篇 |
2012年 | 50篇 |
2011年 | 69篇 |
2010年 | 38篇 |
2009年 | 40篇 |
2008年 | 53篇 |
2007年 | 46篇 |
2006年 | 39篇 |
2005年 | 41篇 |
2004年 | 30篇 |
2003年 | 43篇 |
2002年 | 42篇 |
2001年 | 35篇 |
2000年 | 37篇 |
1999年 | 33篇 |
1998年 | 46篇 |
1997年 | 63篇 |
1996年 | 46篇 |
1995年 | 38篇 |
1994年 | 43篇 |
1993年 | 33篇 |
1992年 | 33篇 |
1991年 | 25篇 |
1990年 | 28篇 |
1989年 | 27篇 |
1988年 | 37篇 |
1987年 | 38篇 |
1986年 | 32篇 |
1985年 | 33篇 |
1984年 | 20篇 |
1983年 | 15篇 |
1982年 | 19篇 |
1980年 | 12篇 |
1978年 | 11篇 |
1977年 | 15篇 |
1941年 | 12篇 |
1940年 | 13篇 |
1939年 | 21篇 |
1938年 | 22篇 |
1935年 | 17篇 |
1933年 | 22篇 |
1932年 | 19篇 |
1931年 | 24篇 |
1930年 | 24篇 |
排序方式: 共有1733条查询结果,搜索用时 15 毫秒
1.
Intracranial circulation: pulse-sequence considerations in three- dimensional (volume) MR angiography 总被引:2,自引:0,他引:2
The technique and feasibility of magnetic resonance (MR) angiography of intracranial vessels were studied in 35 healthy volunteers. Variations in image orientation, repetition time (TR), and flip angle were evaluated to determine their effects on flow-related enhancement. Gradient modifications--including echo time (TE), motion compensation, bandwidth, and field of view--were also studied in an effort to reduce motion-induced phase shifts. Results indicated that a FISP (fast imaging with steady precession) sequence with a TR of 50 msec, TE of 15 msec, velocity compensation in the read and section-select directions, acceleration compensation in the read direction, anisotropic volume, and a 1.25-mm partition thickness produced three-dimensional angiographic MR images that were accurate and reproducible in the depiction of the major intracranial vessels. Difficulties with field of view, persistent signal void secondary to higher-order motion, and spatial resolution remain major problems requiring additional study. 相似文献
2.
3.
4.
Paediatric dacryocystorhinostomy 总被引:1,自引:0,他引:1
KN Hakin FRCS FRCOphth TJ Sullivan FRACO FRACS A Sharma FCOphth † RAN Welham FRCS FCOphth † 《Clinical & experimental ophthalmology》1994,22(4):231-235
Of 258 cases of dacryocystorhinostomy performed on children in the period September 1981 to September 1991, 130 were for simple, unresolved congenital nasolacrimal duct obstruction. Other indications for surgery included punctal agenesis, lacrimal fistula, post-traumatic and post-inflammatory canalicular obstruction. Of 177 children without canalicular pathology, 171 (96%) were relieved of symptoms with one operation, without canalicular intubation. Of 81 cases with canalicular disease, 55 of 70 (79%) who underwent DCR plus canalicular intubation, and 10 of 11 who underwent DCR plus Lester-Jones tube, were substantially improved with one operation. No child required peroperative or postoperative blood transfusion. Dacryocystorhinostomy in childhood, in experienced surgical hands, is a safe procedure, achieving relief of symptoms in most cases, particularly in the absence of canalicular disease. 相似文献
5.
6.
7.
Factors influencing women to undergo screening mammography 总被引:2,自引:0,他引:2
8.
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. 总被引:1,自引:0,他引:1 下载免费PDF全文
C Merkel D Sacerdoti G F Finucci R Zuin G Bazzerla M Bolognesi A Gatta 《British journal of clinical pharmacology》1986,21(6):713-719
Beta-adrenoceptor blockers used in the medical management of portal hypertension decrease liver blood flow. The sporadic onset of hepatic encephalopathy during propranolol treatment was ascribed to this decrease. The aim of the present study was to evaluate the effect of chronic treatment with nadolol on liver blood flow and liver function. Nadolol, a non-cardioselective beta-adrenoceptor blocker, has been reported to be as powerful as propranolol in decreasing portal pressure. Before and after 1 month of treatment with nadolol at a dose reducing heart rate by 25%, in 15 cirrhotic patients with portal hypertension, the following parameters were determined: hepatic venous pressure gradient, hepatic blood flow, galactose eliminating capacity, aminopyrine metabolic activity, ICG clearance and intrinsic hepatic clearance. Hepatic venous pressure gradient and hepatic blood flow were decreased by nadolol. However liver function was not affected by the drug. We conclude that, despite a lowered hepatic blood flow, liver function is not affected by 1 month of nadolol treatment. 相似文献
9.
10.